Bioventix profits will beat forecasts, boost eyed from Siemens link

22nd Aug 2016 09:34

(ShareCast News) - Bioventix revealed that revenues and profits will be ahead of expectations for the full year thanks to currency effects and continued demand for its monoclonal antibodies. Revenue for the year to 30 June will come in at £5.3m, which is at least 11% ahead of the forecast £4.8m and

Read more

Bioventix signs deal to end dispute with Diasource

21st Aug 2014 09:44

Bioventix, an AIM-listed company focused on the development of anti-bodies, has signed an agreement to license intellectual property owned by Belgian company Diasource ImmunoAssays. The two groups had been in dispute over one of Diasource's European patents, but said a licence agreement was "the pr

Read more
2